Showing results (831-840 of 2,814) with videos related to

Sort By:
Pageof 282
Diabetes Technology & Therapeutics|April 26, 2019
Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring SystemDorothee Deiss, Agnieszka Szadkowska, Debbie Gordon, et al.
Diabetes Technology & Therapeutics|May 3, 2019
Changes in Accuracy of Continuous Glucose Monitoring Using Dexcom G4 Platinum Over the Course of Moderate Intensity Aerobic Exercise in Type 1 DiabetesStéphanie Larose, Rémi Rabasa-Lhoret, Amélie Roy-Fleming, et al.
Diabetes Technology & Therapeutics|May 3, 2019
Mobile Health and Technology Usage by Patients in the Diabetes, Nutrition, and Weight Management Clinic at an Urban Academic Medical CenterMary-Catherine Stockman, Katherine Modzelewski, Devin Steenkamp
Diabetes Technology & Therapeutics|September 21, 2021
Landscape of Continuous Glucose Monitoring (CGM) and Integrated CGM: Accuracy ConsiderationsTimothy S Bailey, Shridhara Alva
Diabetes Technology & Therapeutics|May 7, 2019
Flash Glucose Monitoring Accepted in Daily Life of Children and Adolescents with Type 1 Diabetes and Reduction of Severe Hypoglycemia in Real-Life UseAnissa Messaaoui, Sylvie Tenoutasse, Laurent Crenier
Diabetes Technology & Therapeutics|May 12, 2015
Hypoglycemic Accuracy and Improved Low Glucose Alerts of the Latest Dexcom G4 Platinum Continuous Glucose Monitoring SystemThomas A Peyser, Katherine Nakamura, David Price, et al.
Diabetes Technology & Therapeutics|May 2, 2020
Text Message Intervention for Teens with Type 1 Diabetes Preserves HbA1c: Results of a Randomized Controlled TrialDayna E McGill, Lori M Laffel, Lisa K Volkening, et al.
Diabetes Technology & Therapeutics|May 1, 2020
Incidence and Predictors of Dysglycemia and Regression to Normoglycemia in Indian Adolescents and Young Adults: 10-Year Follow-Up of the ORANGE StudyT S Mehreen, R Kamalesh, D Pandiyan, et al.
Diabetes Technology & Therapeutics|July 6, 2010
An advisory protocol for rapid- and slow-acting insulin therapy based on a run-to-run methodologyFabiola Campos-Cornejo, Daniel U Campos-Delgado, Diego Espinoza-Trejo, et al.
Diabetes Technology & Therapeutics|July 6, 2010
The impact of baseline hemoglobin A1c levels prior to initiation of pump therapy on long-term metabolic controlOrit Pinhas-Hamiel, Michal Tzadok, Galit Hirsh, et al.
Pageof 282